Cytogen FCF per Share
The Free Cash Flow per Share of Cytogen (217330.KQ) as of Oct 13, 2026 is -1,596.04 KRW. In the previous year, Free Cash Flow per Share was -1,890.90 KRW — a change of -15.59% (higher).
Get this data via API
Financial Data API
FCF per Share
-1,596.04KRW
YoY
-15.59%
Last updated:
The Cytogen FCF per Share history
3 Years
10 Years
25 Years
Max
| YEAR | FCF per Share | YoY |
|---|---|---|
| -1,596.04KRW | -15.59% | |
| -1,890.90KRW | +4.28% | |
| -1,813.32KRW | +43.41% | |
| -1,264.44KRW | -1.42% | |
| -1,282.67KRW | +52.60% | |
| -840.57KRW | +20.56% | |
| -697.22KRW | -3.79% | |
| -724.67KRW | +63.73% | |
| -442.61KRW | -7.99% | |
| -481.02KRW | +13.73% | |
| -422.94KRW | -99.89% | |
| -389,040.17KRW | — |
Cytogen Stock analysis
Frequently Asked Questions about Cytogen stock
Free Cash Flow per Share of Cytogen is -1,596.04 KRW in 2025.
Free Cash Flow per Share of Cytogen changed from -1,890.90 KRW to -1,596.04 KRW, representing a -15.59% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Free Cash Flow per Share Cytogen since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Cash Flow — Cytogen
All Key Metrics — Cytogen
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth